PRESS RELEASE published on 01/10/2025 at 00:00, 3 months 10 days ago MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test MedMira Inc. receives Health Canada authorization for clinical trials of Multiplo® Complete Syphilis Antibody Test. Innovative solution for active and past syphilis cases Clinical Trials MedMira Inc. Health Canada Syphilis Diagnostic Tool
BRIEF published on 12/31/2024 at 04:05, 3 months 20 days ago MedMira publie ses résultats du premier trimestre 2025 Résultats Financiers Essais Cliniques MedMira Approbation Réglementaire Premier Trimestre De L'exercice 2025
BRIEF published on 12/31/2024 at 04:05, 3 months 20 days ago MedMira Reports First Quarter 2025 Results Financial Results Clinical Trials Regulatory Approval MedMira Q1 FY2025
PRESS RELEASE published on 12/31/2024 at 04:00, 3 months 20 days ago MedMira Reports First Quarter Results FY2025 MedMira Inc. reports on financial results for Q1 FY2025, achieving regulatory milestones for HIV and syphilis tests, anticipating revenue growth. Company expands product portfolio and clinical trials progress in the US Financial Results Clinical Trials MedMira Inc. HIV Test Syphilis Test
BRIEF published on 12/24/2024 at 18:05, 3 months 26 days ago MedMira obtient l'approbation de Santé Canada pour le test rapide Multiplo® TP/HIV Diagnostic Rapide Approbation De Santé Canada Multiplo® TP/VIH VIH Et Syphilis Accessibilité Aux Soins De Santé
BRIEF published on 12/24/2024 at 18:05, 3 months 26 days ago MedMira Gains Health Canada Approval for Multiplo® Rapid TP/HIV Test Health Canada Approval Healthcare Accessibility Multiplo® TP/HIV Rapid Diagnostics HIV And Syphilis
PRESS RELEASE published on 12/24/2024 at 18:00, 3 months 26 days ago MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV MedMira Inc. receives Health Canada approval for Multiplo® Rapid TP/HIV Test, addressing HIV and syphilis crises in Canada. Device offers fast, accurate results, ideal for healthcare settings MedMira Inc. Syphilis HIV Health Canada Approval Multiplo® Rapid TP/HIV Test
BRIEF published on 11/29/2024 at 05:05, 4 months 21 days ago MedMira Announces FY2024 Financial Results FDA Approval Market Strategy MedMira Financial Results HIV Rapid Test Syphilis Testing
BRIEF published on 11/29/2024 at 05:05, 4 months 21 days ago MedMira annonce ses résultats financiers pour l'exercice 2024 Stratégie De Marché Approbation De La FDA Test De Dépistage De La Syphilis Résultats Financiers De MedMira Test Rapide Du VIH
PRESS RELEASE published on 11/29/2024 at 05:00, 4 months 21 days ago MedMira Reports FY2024 Fourth Quarter and Year End Financial Results MedMira Inc. reports FY2024 financial results and updates on FDA approval for the Reveal® G4 Rapid HIV-1/2 antibody test, Syphilis clinical trials, and US distribution agreements Financial Results FDA Approval MedMira Inc. Syphilis Clinical Trials US Distribution Agreements
Published on 04/18/2025 at 23:35, 1 day 9 hours ago urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 04/18/2025 at 01:20, 2 days 7 hours ago Aston Bay Files Technical Report for Storm Copper Project Initial Mineral Resource Estimate
Published on 04/18/2025 at 00:00, 2 days 9 hours ago Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Published on 04/18/2025 at 18:00, 1 day 15 hours ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
Published on 04/18/2025 at 17:54, 1 day 15 hours ago VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
Published on 04/18/2025 at 17:52, 1 day 15 hours ago Market entry in France – Cicor acquires significant business activities of Éolane
Published on 04/18/2025 at 17:45, 1 day 15 hours ago Linedata Services: Déclaration des transactions sur actions propres opération du 16 avril 2025
Published on 04/18/2025 at 17:45, 1 day 15 hours ago Saint-Gobain once again featured on CDP’s “Climate A List”
Published on 04/18/2025 at 17:45, 1 day 15 hours ago Saint-Gobain figure une nouvelle fois sur la « Climate A List » établie par le CDP
Published on 04/18/2025 at 11:16, 1 day 22 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 17 avril 2025
Published on 04/18/2025 at 11:16, 1 day 22 hours ago Disclosure of transactions in own shares from April 14 to April 17, 2025
Published on 04/18/2025 at 07:00, 2 days 2 hours ago Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders